DTL
ADCT icon

Dynamic Technology Lab’s ADC Therapeutics ADCT Stock Holding History

Dynamic Technology Lab’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165K Buy
+43,970
New +$173K 0.03% 759
2023
Q2 		– Sell
-14,332
Closed -$28K – 951
2023
Q1 		$28K Buy
+14,332
New +$52.9K ﹤0.01% 1015
2022
Q4 		– Sell
-16,957
Closed -$82K – 1047
2022
Q3 		$82K Buy
+16,957
New +$123K 0.01% 1037

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dynamic Technology Lab's ADCT Position: Q1 2026 in Review

Dynamic Technology Lab opened a new position in ADC Therapeutics (ADCT) in Q1 2026: 43,970 shares worth $165K. The stake represents 0.03% of the portfolio and ranks #759 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in ADCT as recently as Q1 2023.

Dynamic Technology Lab first reported a position in ADCT in Q3 2022 and has held it in 3 quarters since. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Dynamic Technology Lab held 43,970 shares of ADC Therapeutics worth $165K as of Q1 2026.
  • ADC Therapeutics was a new Dynamic Technology Lab position in Q1 2026.
  • ADC Therapeutics made up 0.03% of Dynamic Technology Lab's portfolio in Q1 2026, its #759 holding.
  • Dynamic Technology Lab first reported a position in ADC Therapeutics in Q3 2022 and has held it in 3 quarters since.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.